Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Saito, Q. Zhang, C. Hui, A. Menzies-Gow, P. Bhavsar, K.F. Chung (London, United Kingdom). Endogenous hydrogen sulfide (H₂S) in serum and sputum as novel biomarker of asthma. Eur Respir J 2012; 40: Suppl. 56, 300

Member's Comments

No comment yet.

Related content which might interest you: Hydrogen sulfide (H2S) in sputum and serum as a novel biomarker of COPD Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Elevated concentration of exhaled hydrogen peroxide in patients with asthma and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 166s Year: 2001 Impact of theophylline/corticosteroid combination therapy on sputum hydrogen sulfide levels in patients with COPD Source: Eur Respir J 2014; 43: 1504-1506 Year: 2014 Concentrations of the hydrogen peroxide and nitrite in exhaled breath condensate as markers of inflammatory lung diseases Source: Annual Congress 2008 - COPD Year: 2008 A new method for measuring hydrogen peroxide concentration in exhaled air in stable COPD patients: reproducibilityand stability Source: Eur Respir J 2001; 18: Suppl. 33, 460s Year: 2001 Measuring exhaled hydrogen sulphide (eH2S) levels in asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 The dynamic of pH, hydrogen peroxide and nitrite in exhaled breath condensate from patients with COPD and asthma exacerbation Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Enhanced level of hydrogen peroxide in expired breath correlates with the plasma concentration of TNFa in patients with lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 556s Year: 2004 Effect of theophylline on endogenous hydrogen sulfide in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 671s Year: 2006 Changes of endogenous hydrogen sulfide in rat model of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 216s Year: 2006 Use of sodium and potassium as dilution markers in the assessment of hydrogen peroxide in exhaled breath condensate (EBC) Source: Eur Respir J 2005; 26: Suppl. 49, 577s Year: 2005 Clinical application of sputum hydrogen sulfide and YKL-40 in Asthma, ACO and COPD Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Prospective nitrite, nitrate and cys-leukotriene (cys-LTs) measurements in EBC (exhaled breath condensate) in asthmatic children and relation to outcome during inhaled steroid (IS) reduction Source: Eur Respir J 2003; 22: Suppl. 45, 534s Year: 2003 Increased concentration of hydrogen peroxide (H2O2) in expired breath condensate of patients with lung cancer and stable chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 247s Year: 2001 Evaluation of hydrogen perioxide in breath condensate in children with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 143s Year: 2002 Relationship between hydrogen peroxide levels in exhaled breath condensate and long term changes in small airway function of patients with asthma Source: Eur Respir J 2007; 30: Suppl. 51, 585s Year: 2007 Quantitative analysis of 8-isoprostane and hydrogen peroxide in exhaled breath condensate Source: Eur Respir J 2004; 23: 189-192 Year: 2004 Simultaneous analysis of sputum and serum biomarkers in adult asthma Source: International Congress 2019 – Clinical implications of asthma management Year: 2019 Detection of angiogenesis, antiangiogenesis and hypoxia related molecules in plasma and exhaled breath condensate (EBC): evaluation of potential biomarkers Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009 Oxidative stress evaluation in exhaled breath condensate (EBC) vs induced sputum (IS) in the assessment of lung diseases Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006